Han Nannan, Li Xing, Wang Yupu, Wang Lin, Zhang Chunye, Zhang Zun, Ruan Min, Zhang Chenping
Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, National Clinical Research Center for Oral Diseases, Shanghai, 200011, China.
J Cancer. 2021 Mar 19;12(10):3045-3056. doi: 10.7150/jca.55580. eCollection 2021.
Tumor-infiltrating immune cells are closely associated with tumor occurrence and progression. The present study explored the potential mechanism of tumor-infiltrating plasmacytoid dendritic cells (pDC) mediating the proliferation and metastasis of cancer cells in oral squamous cell carcinoma (OSCC). pDC distribution was detected by immunofluorescence and flow cytometry. chemotaxis cytokine receptor-4/7 (CXCR-4/7) expression was detected by quantitative polymerase chain reaction and immunohistochemistry. Cell proliferation and migration were measured by CCK-8, colony formation, wound healing and transwell assay. ELISA and western blotting were used to investigate cytokines secretion and NF-κB pathway activity. Tumor-infiltrating pDC in OSCC was significantly increased and associated with tumor size, lymph node (LN) metastasis ( <0.05). Tumor-infiltrating-pDC-conditioned medium from OSCC patients significantly promoted tumor cell proliferation and invasion, which was at least partly mediated via enhancing the CXCR-4 expression of tumor cell. In addition, the activation of NF-κB pathway played a decisive role in the overexpression of CXCR-4, which was further regulated by pDC-derived TNF-α secretion. Tumor-infiltrating pDC promoted oral cancer proliferation and invasion via activating the TNF-α/NF-κB/CXCR-4 pathway, which may serve as a potential immunological target for the treatment of OSCC in the future.
肿瘤浸润免疫细胞与肿瘤的发生和进展密切相关。本研究探讨了肿瘤浸润浆细胞样树突状细胞(pDC)介导口腔鳞状细胞癌(OSCC)癌细胞增殖和转移的潜在机制。通过免疫荧光和流式细胞术检测pDC分布。通过定量聚合酶链反应和免疫组织化学检测趋化因子受体-4/7(CXCR-4/7)表达。采用CCK-8、集落形成、伤口愈合和Transwell实验检测细胞增殖和迁移。采用酶联免疫吸附测定(ELISA)和蛋白质印迹法检测细胞因子分泌和NF-κB通路活性。OSCC中肿瘤浸润pDC显著增加,且与肿瘤大小、淋巴结(LN)转移相关(<0.05)。OSCC患者肿瘤浸润pDC条件培养基显著促进肿瘤细胞增殖和侵袭,这至少部分是通过增强肿瘤细胞CXCR-4表达介导的。此外,NF-κB通路的激活在CXCR-4过表达中起决定性作用,其进一步受pDC分泌的肿瘤坏死因子-α(TNF-α)调控。肿瘤浸润pDC通过激活TNF-α/NF-κB/CXCR-4通路促进口腔癌增殖和侵袭,这可能成为未来治疗OSCC的潜在免疫靶点。